Go Pro

Surrozen (SRZNW) Competitors

$0.0015 0.00 (0.00%)
As of 08/7/2026
This is a fair market value price provided by Massive. Learn more.

SRZNW vs. ALVOW, APLMW, ARAV, BIAFW, and BIVIW

Should you buy Surrozen stock or one of its competitors? Surrozen's main competitors and comparable companies include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), and BioVie (BIVIW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Surrozen compare to Alvotech?

Surrozen (NASDAQ:SRZNW) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, media sentiment, institutional ownership and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surrozen$11.51MN/AN/AN/AN/A
Alvotech$559.42MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
SurrozenN/A N/A N/A
Alvotech N/A N/A N/A

In the previous week, Alvotech had 1 more articles in the media than Surrozen. MarketBeat recorded 2 mentions for Alvotech and 1 mentions for Surrozen. Surrozen's average media sentiment score of 1.87 beat Alvotech's score of 0.93 indicating that Surrozen is being referred to more favorably in the media.

Company Overall Sentiment
Surrozen Very Positive
Alvotech Positive

Summary

Alvotech beats Surrozen on 2 of the 3 factors compared between the two stocks.

How does Surrozen compare to Apollomics?

Apollomics (NASDAQ:APLMW) and Surrozen (NASDAQ:SRZNW) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends, analyst recommendations and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
Surrozen$11.51MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
Surrozen N/A N/A N/A

In the previous week, Apollomics had 2 more articles in the media than Surrozen. MarketBeat recorded 3 mentions for Apollomics and 1 mentions for Surrozen. Surrozen's average media sentiment score of 1.87 beat Apollomics' score of 0.29 indicating that Surrozen is being referred to more favorably in the news media.

Company Overall Sentiment
Apollomics Neutral
Surrozen Very Positive

Summary

Surrozen beats Apollomics on 2 of the 3 factors compared between the two stocks.

How does Surrozen compare to Aravive?

Aravive (NASDAQ:ARAV) and Surrozen (NASDAQ:SRZNW) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, valuation, risk, media sentiment, dividends and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
Surrozen N/A N/A N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Surrozen had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for Surrozen and 0 mentions for Aravive. Surrozen's average media sentiment score of 1.87 beat Aravive's score of 0.00 indicating that Surrozen is being referred to more favorably in the news media.

Company Overall Sentiment
Aravive Neutral
Surrozen Very Positive

Surrozen has higher revenue and earnings than Aravive.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aravive$6.99M0.42-$66.21M-$0.90N/A
Surrozen$11.51MN/AN/AN/AN/A

Summary

Surrozen beats Aravive on 3 of the 5 factors compared between the two stocks.

How does Surrozen compare to bioAffinity Technologies?

bioAffinity Technologies (NASDAQ:BIAFW) and Surrozen (NASDAQ:SRZNW) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, risk, earnings, valuation and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioAffinity Technologies$5.85MN/AN/AN/AN/A
Surrozen$11.51MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
bioAffinity TechnologiesN/A N/A N/A
Surrozen N/A N/A N/A

In the previous week, bioAffinity Technologies had 2 more articles in the media than Surrozen. MarketBeat recorded 3 mentions for bioAffinity Technologies and 1 mentions for Surrozen. Surrozen's average media sentiment score of 1.87 beat bioAffinity Technologies' score of 0.73 indicating that Surrozen is being referred to more favorably in the news media.

Company Overall Sentiment
bioAffinity Technologies Positive
Surrozen Very Positive

Summary

Surrozen beats bioAffinity Technologies on 2 of the 3 factors compared between the two stocks.

How does Surrozen compare to BioVie?

Surrozen (NASDAQ:SRZNW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surrozen$11.51MN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
SurrozenN/A N/A N/A
BioVie N/A N/A N/A

In the previous week, BioVie had 1 more articles in the media than Surrozen. MarketBeat recorded 2 mentions for BioVie and 1 mentions for Surrozen. Surrozen's average media sentiment score of 1.87 beat BioVie's score of 1.23 indicating that Surrozen is being referred to more favorably in the media.

Company Overall Sentiment
Surrozen Very Positive
BioVie Positive

Summary

Surrozen beats BioVie on 2 of the 3 factors compared between the two stocks.

Get Surrozen News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRZNW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRZNW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SRZNW vs. The Competition

MetricSurrozenBiotechnology IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$3.71B$6.99B$13.03B
Dividend YieldN/A3.76%2.58%10.72%
P/E RatioN/A10.52269.5525.26
Price / SalesN/A1,290.58597.75101.23
Price / CashN/A103.0170.5350.75
Price / BookN/A17.5013.086.33
Net IncomeN/A-$13.32M$3.45B$347.70M
7 Day PerformanceN/A1.53%1.02%0.97%
1 Month PerformanceN/A1.39%1.68%0.92%
1 Year PerformanceN/A55.83%67.42%20.45%

Surrozen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SRZNW
Surrozen
N/A$0.00
flat
N/A-86.4%$0.00$11.51MN/A80
ALVOW
Alvotech
N/A$0.15
flat
N/A-87.2%$0.00$559.42MN/A4
APLMW
Apollomics
N/A$0.02
-1.6%
N/A-30.7%$0.00$8.50MN/A59
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00N/AN/A20
BIAFW
bioAffinity Technologies
N/A$0.08
+9.1%
N/A-26.6%$0.00$5.61MN/A10

Related Companies and Tools


This page (NASDAQ:SRZNW) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners